Enlarge / Lady receives an experimental COVID-19 vaccine on the College of Massachusetts Medical Faculty in Worcester, MA on September 04, 2020, as a part of a scientific trial. (credit score: Getty | Boston Globe)
In a rare transfer Tuesday, 9 high pharmaceutical executives made a public pledge that they won’t prematurely launch a COVID-19 vaccine and that they are going to solely search federal approval to distribute a vaccine after rigorous moral and scientific requirements are met.
The pledge was signed by the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi. All the represented firms are engaged on a vaccine towards COVID-19 and 4—AstraZeneca, Moderna, and a three way partnership between BioNTech and Pfizer—have vaccines in part three scientific trials.
The vow seems to be a coordinated resistance to stress from the Trump administration, which is pushing for a rollout of a vaccine by November 1, simply earlier than the presidential election. Final week, the Facilities for Illness Management and Prevention informed states to be prepared to start out distributing vaccines by November 1.
Learn 10 remaining paragraphs | Feedback
